Core Viewpoint - The article highlights the significant global expansion of Sizeray Intelligent Medical, particularly the successful commercialization of the Kando Robot® SR2000, marking a transformative shift in minimally invasive surgery worldwide [1][9]. Group 1: Technological Advancements - The Kando Robot® SR2000 has gained international recognition due to its innovative technology and proven clinical capabilities, which are foundational for its global market expansion [2]. - It features a multi-modal high-performance imaging navigation platform that integrates real-time 4K fluorescence navigation, ultrasound positioning, and pre-operative CT/MRI data, providing robust decision support for surgeons [3]. - The design of the open multi-screen control console has won prestigious awards, including the Red Dot Award and IDEA Award, underscoring its excellence in remote surgical applications [6]. Group 2: Clinical Applications and Approvals - The Kando Robot® SR2000 has received regulatory approvals from multiple global health authorities, enabling its use in various complex minimally invasive surgeries across different specialties, including urology, general surgery, gynecology, and thoracic surgery [8]. Group 3: Global Market Presence - Sizeray Intelligent Medical has successfully expanded its market presence to nearly 40 countries across Asia, Europe, Latin America, and Africa, demonstrating the effectiveness of its overseas exclusive agency model [9]. - The ongoing delivery of orders from various countries reflects the solid implementation of its globalization strategy and the international market's recognition of the quality and value of this "Chinese-made" high-end surgical robot [9]. Group 4: Future Outlook - The company aims to continue its mission of making safer and more precise robotic surgeries accessible to healthcare institutions worldwide, transitioning from a technological pioneer to a widespread market player [10].